# Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

> **NCT00509691** · PHASE1 · COMPLETED · sponsor: **University of Louisville** · enrollment: 20 (actual)

## Conditions studied

- Cancer

## Interventions

- **BIOLOGICAL:** cytomegalovirus pp65-specific cytotoxic T lymphocytes
- **GENETIC:** polymerase chain reaction
- **OTHER:** diagnostic laboratory biomarker analysis
- **OTHER:** flow cytometry
- **OTHER:** immunologic technique

## Key facts

- **NCT ID:** NCT00509691
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00509691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00509691, "Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00509691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*